Follow the news from members of the cluster, who specialize in immuno biotherapy, regenerative medicine, radiopharmaceutical and innovative technologies for biotherapies.

Filter news by

OSE Immunotherapeutics: last news

OSE Immunotherapeutics present significant data on Selective Anti-SIRPa OSE-172 (Effi-DEM) OSE Immunotherapeutics announced that the Company presented in oral session significant data on... View Article